
“EW Healthcare Partners is not so much an Investor as a Partner in building successful businesses as was my experience with EUSA Pharma.”
Bryan Morton
Chairman, EUSA Pharma
European specialty pharmaceutical company focused on oncology and critical care.
EUSA will have marketed products, and full infrastructure and sales force in key European markets, and modest operations and sales in the United States. Their assets include four specialty products: Caphosol for oral mucositis, Collatamp for post-operative infections, Custodial for organ transport, and Xenazine for movement disorders.
“EW Healthcare Partners is not so much an Investor as a Partner in building successful businesses as was my experience with EUSA Pharma.”
Chairman, EUSA Pharma